Efficiently Recording the Eye-Hand Coordination to Incoordination Spectrum
March 21st, 2019
7.6K views
Cerebral injury can damage both ocular and somatic motor systems. Characterization of motor control post-injury affords biomarkers that assist in disease detection, monitoring, and prognosis. We review a method to measure eye-hand movement control in health and in pathologic incoordination, with look-and-reach paradigms to assess coordination between eye and hand.
Overview
This study reviews a method for measuring eye-hand movement control in both healthy individuals and those with pathologic incoordination. By utilizing look-and-reach paradigms, the research aims to assess the coordination between eye and hand movements, which can serve as biomarkers for disease detection and monitoring post-cerebral injury.
Key Study Components
Area of Science
- Neuroscience
- Motor Control
- Ocular Function
Background
- Cerebral injuries can affect both ocular and somatic motor systems.
- Understanding motor control post-injury is crucial for developing biomarkers.
- Eye movements provide insights into cerebral function.
- Current studies often lack protocols for concurrent eye movement recordings.
Purpose of Study
- To characterize eye-hand movement control in health and pathology.
- To assess coordination between eye and hand movements.
- To provide objective analysis for disease detection and prognosis.
Methods Used
- Three-dimensional recordings of simultaneous eye-hand movements.
- Visually guided saccade to reach tasks.
- Comparative analysis between patients with chronic MCA stroke and healthy controls.
- Objective analysis of eye movements to monitor physiologic phenotype.
Main Results
- Identification of eye and hand impairments in stroke patients.
- Demonstration of the effectiveness of the measurement method.
- Evidence supporting the use of eye movement analysis in clinical settings.
- Insights into the relationship between ocular and motor function post-injury.
Conclusions
- The method provides valuable biomarkers for monitoring motor control.
- Eye-hand coordination assessment can enhance disease detection.
- Further research is needed to refine these techniques for broader applications.
Frequently Asked Questions
What is the significance of eye-hand coordination?
Eye-hand coordination is crucial for performing tasks that require visual guidance and motor control.
How does cerebral injury affect motor systems?
Cerebral injury can impair both ocular and somatic motor systems, affecting coordination and control.
What methods are used to assess eye-hand movements?
The study employs three-dimensional recordings and visually guided tasks to assess movements.
Why is objective analysis of eye movements important?
Objective analysis helps in accurately detecting and monitoring impairments in motor control.
What populations were compared in this study?
Patients with chronic MCA stroke were compared to healthy controls.
What are the potential applications of this research?
The findings can assist in disease detection, monitoring, and prognosis in clinical settings.
Executive Industry Relevance
Quantitative assessment of eye-hand coordination provides a mechanistic biomarker for neural injury, supporting target validation in neurorehabilitation and CNS therapeutic development. Concurrent dual-effector recordings enable objective phenotyping of motor control deficits, informing go/no-go decisions in preclinical and clinical-stage programs. This approach enhances predictive confidence by linking ocular and upper limb function to shared neural pathways affected in stroke and traumatic brain injury.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by quantifying dissociation between eye and hand motor control in disease models.
- Operational Value: Enables biological de-risking through objective, reproducible measurement of visuomotor integration.
- Predictive Value: Supports portfolio triage by identifying coordination impairment as a translatable biomarker of CNS pathway integrity.
Screening & Assay Development
- Assay Readiness: Prepares validated biological systems for downstream compound screening via standardized 3D eye-hand task protocols.
- Quantitative Output: Delivers scalable, high-fidelity data on saccade latency, reach error, and fixation stability for compound effect evaluation.
- Platform Reuse: Facilitates cross-study consistency through fixed sampling rates, calibration procedures, and head movement tolerance thresholds.
Translational & Preclinical Research
- Disease Relevance: Models chronic MCA stroke pathophysiology to assess eye-hand incoordination as a functional outcome.
- Translational Continuity: Bridges discovery findings to preclinical validation by capturing reciprocal compensation in eye and hand movement control.
- Risk-Adjusted Advancement: Informs go/no-go decisions by quantifying coordination deficits that correlate with functional assessments like the 9-hole peg test.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from target hypothesis testing through lead optimization to preclinical validation by providing quantitative, biomarker-rich readouts of visuomotor function.
- Discovery Biology: Supports mechanistic de-risking by clarifying neural pathways underlying eye-hand coordination in injury models.
- Screening: Enables assay standardization through reproducible saccade-to-reach task execution and fixed target presentation parameters.
- Analytics: Generates quantitative dependent variables including saccade onset latency, reach endpoint error, and fixation stability for intergroup comparison.
- Translational Research: Connects to preclinical continuity by characterizing impairment and recovery patterns in eye and hand movement control post-injury.
- Enterprise Reuse: Establishes a reusable capability for longitudinal tracking of motor control across disease models and therapeutic interventions.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity by providing objective, concurrent measurement of eye and hand motor control.
- Operational Value: Ensures standardization and reproducibility through fixed sensor placement, calibration protocols, and environmental controls.
- Strategic Value: Improves go/no-go decisions by delivering biomarker data that predicts functional outcomes in neurorehabilitation.
- Portfolio Impact: Enables risk-adjusted prioritization by linking coordination impairment to neural pathway integrity and recovery potential.
Implementation Considerations
- Requires expertise in oculomotor and kinematic data collection, synchronization, and post-processing.
- Dependent on electromagnetic motion tracking infrastructure, necessitating safety screening for implants and pregnancy.
- Necessitates cross-team standardization of task instructions, target presentation, and movement tolerance criteria.
- Involves adaptation considerations for varying levels of motor impairment, including head movement range and visual field access.
- Limited by the physical footprint and setup time of dual-tracking systems in clinical or high-throughput screening environments.
Biopharma FAQs
Why does null hypothesis testing matter for target validation in eye-hand coordination studies?
Null hypothesis testing determines whether observed differences in saccade latency or reach error between stroke patients and controls exceed expected variability, providing statistical confidence in target engagement and pathway modulation.
How does independent variable isolation fit the discovery pipeline for visuomotor biomarker development?
Isolating the independent variable (e.g., stroke status) allows attribution of changes in eye-hand coordination to neural injury rather than confounding factors, supporting causal inference in target validation.
What quantitative dependent variable measurements enable preclinical model assessment of eye-hand control?
Dependent variables such as saccade onset latency, reach endpoint error, and fixation stability provide quantifiable, objective readouts to compare model conditions and track therapeutic effects over time.
Why do replication requirements matter for cross-functional collaboration in motor control biomarker studies?
Replication ensures that coordination impairment metrics are consistent across operators, sites, and sessions, enabling reliable data sharing between discovery, preclinical, and clinical teams.
What statistical analysis capabilities are required before implementing eye-hand coordination assays in drug discovery?
Implementation requires capability for group comparison tests (e.g., t-tests, ANOVA), effect size calculation, and correlation analysis with functional outcomes to support go/no-go decision-making.
